Medical
About Us
Investor Relations
The Company considers profit ret urn for all shareholders to be one of the most important management issues. Taking into consideration the internal reserves necessary for strengthening financial constitution and carrying out progress business expansion, the fundamental policy implemented by the Company is providing a stable dividend. More specifically, the goal is continuing allotment with dividend ratios of 30% of more on a consolidated basis.
item | Dividend amount per share (yen) | Dividend payout ratio (%) |
---|---|---|
March 31, 2024 | 51 | 71.1 |
March 31, 2023 | 51 | 32.9 |
March 31, 2022 | 51 | 30.3 |
March 31, 2021 | 41 | 30.0 |
March 31, 2020 | 30 | 31.3 |
March 31, 2019 | 30 | 32.0 |
March 31, 2018 | 25 | 35.1 |
March 31, 2017 | 25 | 31.4 |
March 31, 2016 |
20 |
30.1 |
* Implementation of stock split * On of April 1, 2018, 1: 2 stock split. Accordingly, dividend amount converted into base after split before fiscal year ended Mar. 31, 2018.
Management
policy
Stock
Information